维普期刊资源整合服务平台（V6.5）

150篇 您的检索式：作者名="Siu LL"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Phase I and phar-macologic study of OSI -774, an epidermal growth factor receptor tyrosine kinase inibitor, in patients with advanced solid malignancies显示文摘	Hidalgo M Siu LL Nemunaitis J	2001	J Clin Oncol2001，19，：	1
2	Phase Ⅱ study of erlotinib (OSI-774) in patients with metastatic colorectal cancer显示文摘	Townsley CA Major P Siu LL	2006	Br J Cancer2006，94，8：	1
3	Future directions in the treatment of neuroendocrine tumors : consensus report of the Na- tional Cancer Institute Neuroendocrine Tumor clinical trials plan- ning meeting显示文摘	Kulke MH Siu LL Tepper JE	2011	J Clin Oncol2011，29，7：	1
4	Nasopharyngeal carcinoma: the next challenges显示文摘	Razak AR Siu LL Liu FF	2010	Eur J Cancer2010，46，11：	1
5	Phase Ⅰ and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies 显示文摘	Siu LL Nemunaitis J	2001	J Clin Oncol2001，19，：	1
6	Pharmacodynamic evaluation of the epidermal growth factor receptor inhibitor OSI -774 in human epidermis of cancer patients 显示文摘	Malik SN Siu LL Rowinsky EK	2003	Clin Cancer Res2003，9，：	1
7	Phase Ⅱ study of erlotinib(OSI774)in patients with metastatic colorectal cancer显示文摘	Townsley CA Major P Siu LL	2006	Br J Cancer2006，94，8：	1
8	Natural killer cell malignancies:clinicopathologic and molecular features显示文摘	Siu LL Chan JK Kwong YL	2002	Histol Histopathol2002，17，2：	1
9	Phase Ⅰ trial of sorafenib and gemcitabine in advanced solid tumors with an expanded eohoa in advanced pancreatic cancer显示文摘	Siu LL Awada A Takimoto CH	2006	Clin Cancer Res2006，12，1：	1
10	Phase Ⅰ and pharmacologic study of the human DNA methyltransferase antisense oligodeoxynucleotide MG98 given as a 21-day continuous infusion every 4 weeks显示文摘	DAVIS AJ GELMON KA SIU LL	2003	Invest New Drugs2003，21，1：	1
11	Phase I study of the muhidrug resistance inhibitor zosuquidar administered in combination with vinorelbine in patients with advanced solid tumors 显示文摘	Le LH Moore MJ Siu LL	2005	Cancer Chemother Pharmacol2005，56，2：	1
12	Nasopharyngeal carcinoma:the next challenges 显示文摘	Razak AR Siu LL Liu FF	2010	Eur J Cancer2010，46，11：	1
13	A phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervix显示文摘	Knox JJ Siu LL Chen E	2005	Eur J Cancer2005，41，：	1
14	First-in-class, first-in-human phase I re- suits of targeted agents: highlights of the 2008 American society of clinical oncology meeting显示文摘	Molckovsky A Siu LL	2008	J Hematol Oncol2008，1，：	1
15	Molecular-targeted therapies in the trentment of squamous cell carcinomas of the head and neck显示文摘	Le Tourneau C Siu LL	2008	Curr Opin Oncol2008，20，3：	1
16	Phase Ⅱ trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinoma显示文摘	Elser C Siu LL Winquist E	2007	J Clin Oncol2007，25，24：	1
17	Molecularly targeted oncology therapeutics and prolongation of the QT interval 显示文摘	Strevel EL Ing D J Siu LL	2007	J Clin Oncol2007，25，22：	1
18	A phase Ⅰ and pharmacokinetic study of SAM486A,a novel polyamine biosynthesis inhibitor,administered on a daily-times-five every-three-week schedule in patients with advanced solid malignancies显示文摘	Siu LL Rowinsky EK Hammond LA	2002	Clin Cancer Res2002，8，7：	1
19	Characterization of the lung toxicity of the cell cycle inhibitor temsirolimus 显示文摘	Duran I Siu LL Oza AM	2006	Eur J Cancer2006，42，12：	1
20	Tolerability of the intergroup 0099 ( INT 0099) regimen in locally advanced nasopharyngeal cancer with a focus on patient's nutritional status显示文摘	Bahl M Siu LL Pond GR	2004	Int J Radiat Oncol Biol Phys2004，60，4：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示